Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,847 total articles
Schneider’s diversified transport mix, recent accretive M&A and a low leverage profile make it a compelling swing trade as industry pricing and volumes recover. Entry at $36.00, stop $33.00, target $41.50 over a 45 trading day horizon.
Nvidia has turned the messy economics and engineering overhead of AI into a product-led moat. Exceptional margins, huge free cash flow and tight competitive differentiation justify paying up, but the valuation leaves little margin for cyclical weakness. This trade targets a measured long exposure with a mid-sized position, defined stop and a 34% up…
Meta is investing aggressively in AI infrastructure, which suppresses near-term free cash flow. With $40.98B in trailing free cash flow, a $1.51T market cap and attractive operating returns, the company is positioned to produce a sharp FCF recovery once capex cools and AI monetization scales. This trade idea outlines a pragmatic long (buy) with ent…
Betterware de México (BWMX) combines a low-teens P/E, a recently closed $250M Tupperware Latin America acquisition at a bargain multiple, and a meaningful dividend yield. With clear synergies in manufacturing and distribution across Mexico and Brazil, the stock looks attractively priced around $16.70. This trade plan targets $22.50 over a long-term…
Colony Bankcorp (CBAN) finished a strong fiscal run, trades near its 52-week high but remains inexpensive on several measures. We lay out a tactical long with strict risk controls and a 46-180 trading day time frame to capture a valuation re-rating and continued FCF conversion.
Northern Star Resources has completed a multi-year capex cycle. With large processing investments now commissioned and sustaining spend set to fall, the company is positioned to convert production into outsized free cash flow. We view this as a constructive structural change that supports a buy: entry $11.50, target $15.00, stop $9.50 over a 180 tr…
L3Harris sits squarely in the crosshairs of a defense spending rerating: strong backlog across missiles, sensors and battlefield communications, a high-margin propulsion business (Aerojet Rocketdyne), and healthy free cash flow. At $288 the stock offers asymmetric upside into persistent geopolitical-driven procurement tailwinds while trading at rea…
Corvus (CRVS) is a strong buy into clinical catalysts tied to its atopic dermatitis candidate soquelitinib and ongoing T-cell lymphoma programs. The company has fresh capital from an upsized offering, meaningful insider buying, and clear trial traction that has already driven strong YTD performance. This trade idea outlines an actionable entry, sto…
Tyra Biosciences (TYRA) is a clinical-stage precision oncology company valued at roughly $1.58B. With a pipeline focused on selective FGFR inhibition and a binary clinical catalyst in SURF302, TYRA offers a high-risk, high-reward trade: a positive readout could re-rate the stock materially, while negative data would likely compress the valuation. T…
Amazon's latest quarter delivered a stronger-than-expected operational beat that re-established the case for owning the stock. The core drivers are continued strength in cloud demand, improving advertising monetization, and structural margin recovery in retail logistics. This trade idea lays out an actionable long with precise entry, target, and st…
AMD looks set to convert aggressive capital spending into a material increase in supply and differentiated product sets that should support revenue and margin expansion over the coming months. This trade idea backs a tactical long with a $140 entry, $175 target and $120 stop on a mid-term (45 trading days) horizon.
Veracyte's focus on higher-margin oncology products - notably Prosigna and the emerging TrueMRD platform - creates a plausible growth runway. Fundamentals show solid free cash flow and a manageable market cap; technicals are mixed, offering a tactical entry near $47.22. This trade idea sets an entry at $47.22, a stop at $42.00, and a target at $62.…
DoorDash (DASH) has staged a technical breakout above its short- and medium-term moving averages with bullish MACD and rising volume. Fundamentals show strong revenue growth and solid free cash flow, but valuation is rich. This trade idea leans on momentum and a clearly defined risk-reward: enter at $216.35, stop at $200.00, target $260.00 over a m…
Crescent Energy just put up numbers that validate its returns-driven strategy: meaningful free cash flow, a market-cap of about $3.8B and a dividend that yields in the mid-single digits. With the Vital Energy merger dialing in $90-100M of expected annual savings and valuation metrics trading well below peers on an EV/EBITDA and EV/FCF basis, we see…
Trulieve (TRUL) is the first U.S.-headquartered cannabis company listed on the NYSE and, in our view, represents an actionable long with defined risk controls. The company blends a scaled retail network, strong brand recognition in medical and adult-use markets, and a path to margin expansion. This trade idea lays out an entry, stop, targets, catal…
Dell Technologies has re-emerged as a primary beneficiary of the AI infrastructure buildout. Strong AI-optimized server sales, improving free cash flow, and a still-reasonable revenue multiple leave meaningful upside from current levels. This trade idea lays out an actionable long with entry, targets, stop, catalysts and risks across short, mid and…
Infleqtion (INFQ) is a neutral-atom quantum hardware company that combines meaningful government funding, customer traction and a strategic Nvidia relationship. The stock is currently trading near $11.94 and offers an asymmetric payoff if scaling and commercialization milestones arrive. This is a high-risk long trade with a defined entry at $11.94,…
Nvidia's market value looks headline-large, but the company's cash generation, profitability, low leverage and dominant share in AI accelerators make today's price an attractive entry for a disciplined long. This trade lays out an exact entry, stop and target for a long term (180 trading days) horizon and explains why the risk-reward favors owning …
Palantir's Q2 acceleration and new partnerships (notably with Nvidia) push its AI platforms into the center of enterprise and sovereign use cases. Growth is running well ahead of the valuation’s implicit expectations; this trade idea buys the momentum while protecting capital with a disciplined stop. We upgrade to buy with a mid-term trade plan aim…
Loar Holdings is priced like a high-growth aerospace play. The recent cadence of record sales, margin lift and accretive M&A argues for buying growth despite a rich P/E and P/S. This trade plan lays out a precise entry at $71.00, a stop at $62.00, and a target of $85.00 over a 180 trading-day horizon.
Aris Mining ($ARIS) is trading at a reasonable multiple while showing bullish technicals and benefiting from a stronger gold market. The company’s Colombian asset base, margin profile and share structure support a long trade targeting a move back above the 52-week high. This idea lays out entry, stop and target with a 46-180 trading day horizon.
Brookfield Asset Management ($BAM) looks reasonably priced today around $52.50. Valuation metrics (P/E ~33, P/B ~11) imply limited upside from steady cash flows, but recent strategic moves - notably a ~$7B Aypa Power battery deal and expanded deals with fuel-cell and data center players - create a plausible re-rating path if Brookfield captures AI-…
NioCorp (NB) trades at $5.345 after a run of positive headlines and analyst coverage. The Elk Creek project is one of the more advanced U.S. critical-minerals developments, but financing optionality remains the key binary. I take a tactical short over the mid term (45 trading days) to express skepticism that the company will secure the non-dilutive…
Datadog (DDOG) is a category leader in full-stack observability with high-quality FCF, double-digit growth in AI-related revenue, and strong institutional interest. Valuation is rich (roughly $84B market cap, ~21x price-to-sales) but the company’s product stickiness, expanding AI telemetry revenue, and large TAM support a tactical long. Trade plan …
Green Thumb Industries (GTBIF) trades like a beaten cannabis name but is delivering growing retail scale, attractive valuation metrics (PE 13.7, PB 0.85) and improving technicals. This trade idea is a directional long: enter $6.80, stop $5.80, target $10.50 - horizon 180 trading days. Manage position size and respect the stop; catalysts include sto…
